Latest Asx Listing News

Andromeda Metals has addressed a recent spike in its share price and trading volume, attributing the movement to a newly released research report and an imminent High Purity Alumina scoping study.

Blue Energy Limited has addressed ASX concerns over the timing of its Cleansing Notice related to the grant of Production Licence PL 1034 for its Sapphire gas project, confirming compliance with disclosure rules despite delayed formal notification.

Artrya Limited has completed the first tranche of its A$75 million placement, raising approximately A$60 million to advance its AI-driven coronary artery disease platform. Eligible shareholders can now participate in a Share Purchase Plan at the same price.

PolarX Limited has completed a $5.09 million share placement, issuing over 339 million shares at 1.5 cents each under its ASX Listing Rule 7.1 capacity. The move strengthens the company’s capital base without the need for a formal disclosure document.

Bubs Australia has appointed Paul Jensen as its new Independent Chair and Joe Coote as Managing Director and CEO, signaling a fresh leadership chapter for the infant formula and dairy company.

Peninsula Energy has updated its prospectus to announce the appointment of Tejal Magan as a Non-executive Director, enhancing its governance ahead of ongoing equity offers.

Bastion Minerals has appointed seasoned geologist Ray Muskett to its board and secured shareholder approval to issue up to 750 million new shares, positioning the company for an accelerated exploration phase.

OZZ Resources Limited has provided a detailed update to ASX on its prolonged voluntary suspension, citing procedural delays in Zimbabwe and a pending joint venture at its Maguires Reward Project. The company outlines exploration activities, expenditure, and plans to resume trading.

Botala Energy has disclosed an inadvertent breach of ASX Listing Rule 10.11 involving the issuance of shares to a related party without shareholder approval, and is taking corrective steps to resolve the issue.

Mirvac Group director Rosemary Beryl Hartnett was granted 41,111 rights to acquire stapled securities under the company’s Non-Executive Director Fee Sacrifice Rights Plan, reflecting a strategic move in director remuneration.

Control Bionics Limited has confirmed its compliance with ASX continuous disclosure rules following an inquiry about the timing and content of its financial results announcements.

Highfield Resources clarifies its financial position amid funding uncertainties, confirming ongoing talks with major investors and a standstill on matured convertible notes. The company maintains its commitment to the Muga Potash Project despite setbacks.